E
Entia Biosciences Inc
OTC:ERGO
Entia Biosciences Inc
OTC:ERGO
Price:
0.001
USD
400%
Market Closed
Market Cap:
$33.7k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
E
|
Entia Biosciences Inc
OTC:ERGO
|
US |
|
L
|
Labiana Health SA
MAD:LAB
|
ES |
|
R
|
Royal Gold Inc
F:RG3
|
US |
Intrinsic Value
Not Available for ERGO
There is not enough data to reliably calculate the intrinsic value for Entia Biosciences Inc.
Do our valuations actually work? See backtest results .
Alternatives to ERGO
Fundamental Analysis
What Entia Biosciences Does
Entia Biosciences, Inc. operates as a biotechnology company. The company is headquartered in Sherwood, Oregon. The company went IPO on 2007-11-01. The firm also develops and markets health-related nutraceuticals and cosmeceuticals. ErgoD2 is a pharmaceutical-grade organic compound created from whole foods that contain the micro-nutrients L-ergothioneine, an amino acid that has a transporter (SLC22A4) in every human being, and vitamin D2.
- Headquarters
- United States of America US
- IPO date
- Nov 1, 2007
Financials
Revenue & Expenses Breakdown
Entia Biosciences Inc
Entia Biosciences Inc
Efficiency
Earnings Waterfall
Entia Biosciences Inc
Entia Biosciences Inc